Letter to the editor on "Radiogenomics of intrahepatic cholangiocarcinoma predicts immunochemotherapy response and identifies therapeutic target"

Yuqian Liu^{1

2

3

4}, Ruiyun Guo^{1

2

3

4}, Jun Ma^{1

2

3

4

5}

Affiliations

¹ Hebei Medical University-Galway University Stem Cell Research Center, Hebei Medical University, Shijiazhuang, Hebei Province, China.
² Hebei Research Center for Stem Cell Medical Translational Engineering, Hebei Province, China.
³ Hebei Technology Innovation Center for Stem Cell and Regenerative Medicine, Hebei Province, China.
⁴ Hebei International Joint Research Center for Stem Cell and Regenerative Medicine, Hebei Province, China.
⁵ Department of Human Anatomy, Hebei Medical University, Hebei Province, China.

Comment

Yuqian Liu et al. Clin Mol Hepatol. 2026 Jan.

. 2026 Jan;32(1):e13-e15.

doi: 10.3350/cmh.2025.0377. Epub 2025 Apr 23.

Yuqian Liu^{1

2

3

4}, Ruiyun Guo^{1

2

3

4}, Jun Ma^{1

2

3

4

5}

¹ Hebei Medical University-Galway University Stem Cell Research Center, Hebei Medical University, Shijiazhuang, Hebei Province, China.
² Hebei Research Center for Stem Cell Medical Translational Engineering, Hebei Province, China.
³ Hebei Technology Innovation Center for Stem Cell and Regenerative Medicine, Hebei Province, China.
⁴ Hebei International Joint Research Center for Stem Cell and Regenerative Medicine, Hebei Province, China.
⁵ Department of Human Anatomy, Hebei Medical University, Hebei Province, China.

No abstract available

Keywords: Immune checkpoint inhibitors; Intrahepatic cholangiocarcinoma; Radiogenomics; Spatial transcriptomics.

Conflict of interest statement

Conflicts of Interest

The authors have no conflicts to disclose.

Radiogenomics of intrahepatic cholangiocarcinoma predicts immunochemotherapy response and identifies therapeutic target.
Ji GW, Xu ZG, Liu SC, Cao SY, Jiao CY, Lu M, Zhang B, Yang Y, Xu Q, Wu XF, Wang K, Xia YX, Li XC, Wang XH. Ji GW, et al. Clin Mol Hepatol. 2025 Jul;31(3):935-959. doi: 10.3350/cmh.2024.0895. Epub 2025 Feb 10. Clin Mol Hepatol. 2025. PMID: 39924997 Free PMC article.

1. Ji GW, Xu ZG, Liu SC, Cao SY, Jiao CY, Lu M, et al. Radiogenomics of intrahepatic cholangiocarcinoma predicts immunochemotherapy response and identifies therapeutic target. Clin Mol Hepatol. 2025;31:935–959. - PMC - PubMed
1. Ma L, Hernandez MO, Zhao Y, Mehta M, Tran B, Kelly M, et al. Tumor cell biodiversity drives microenvironmental reprogramming in liver cancer. Cancer Cell. 2019;36:418–430.e6. - PMC - PubMed
1. Lubner MG, Smith AD, Sandrasegaran K, Sahani DV, Pickhardt PJ. CT texture analysis: definitions, applications, biologic correlates, and challenges. Radiographics. 2017;37:1483–1503. - PubMed